Business · World

Abbott Raises 2026 Profit Guidance Amid Rising Sales

1 sourceFirst reported 5 days agoUpdated 5 days ago

AI summary: catch up in 20 seconds

Abbott Laboratories raised its profit guidance for 2026 following a stronger-than-expected second quarter.
The company reported improved performance across most of its business lines.
The updated outlook reflects increased sales across its various segments.
This guidance boost indicates positive financial momentum for Abbott.

Generated by AI from the 1 sources below · always verify with the originals

AI summary: catch up in 20 seconds

Summarising the coverage…

Generated by AI from the 1 sources below · always verify with the originals

All coverage (1)

Sign in to join the discussion.

No comments yet. Be the first to join the discussion.

AI summary: catch up in 20 seconds

Abbott Laboratories raised its profit guidance for 2026 following a stronger-than-expected second quarter.
The company reported improved performance across most of its business lines.
The updated outlook reflects increased sales across its various segments.
This guidance boost indicates positive financial momentum for Abbott.

Generated by AI from the 1 sources below · always verify with the originals